RIPK3 and neoplasm: Induction of necroptosis in tumor cells by triggering RIPK3 resulted in the release of damage-associated molecular pattern molecules, subsequent dendritic cell activation, and priming of tumor antigen-specific IFNγ-producing T cell (44).